Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,010,696
-$1,593,828 QoQ
Shares Held
76,540
-51.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#133
of 421 holders
Holding Since
Jun 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MOORE CAPITAL MANAGEMENT, LP holds $55,779,724 across 7 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,430,654 | $22,718,785 | |
| 2 | ZTS |
Zoetis Inc.
|
202,749 | $14,569,543 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
848,336 | $8,483,360 | |
| 4 | PRGO |
PERRIGO Co plc
|
566,924 | $5,890,340 | |
| 5 | ALKS |
Alkermes plc.
This page
|
76,540 | $4,010,696 | |
| 6 | INCR |
Intercure Ltd.
|
19,455 | $107,000 | |
| 7 | ALVO |
Alvotech
|
50,000 | $0 |
All Filings in ALKS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,010,696 | 76,540 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,604,524 | 158,499 | Shares | Sole | 2026-05-15 | |
| 2023-06-30 | $469,500 | 15,000 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||